Expand DERM Menu
DERM MENU

DERM Latest Press Releases

-- December 10, 2025 --

Journey Medical Corporation Announces Publication of Clinical Trial Results Assessing the Impact of Emrosi (DFD-29) on Microbial Flora of Healthy Adults in the Journal of Drugs in Dermatology Globe Newswire 8:30 AM

-- November 12, 2025 --

Journey Medical Corporation Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights Globe Newswire 4:01 PM

-- November 5, 2025 --

Journey Medical Corporation to Announce Third Quarter 2025 Financial Results on November 12, 2025 Globe Newswire 8:30 AM

-- October 24, 2025 --

Journey Medical Corporation Reports Combined Emrosi (DFD-29) Phase 3 Clinical Trial Efficacy Data Analysis Presented at the 2025 Fall Clinical Dermatology Conference Globe Newswire 8:30 AM

-- October 8, 2025 --

Journey Medical Corporation to Participate in October 2025 Investor Conferences Globe Newswire 8:30 AM

-- September 3, 2025 --

Journey Medical Corporation to Participate in September 2025 Investor Conferences Globe Newswire 8:30 AM

-- August 20, 2025 --

Presenting on Emerging Growth Conference 85 Day 2 on August 21; Register to live stream Globe Newswire 7:00 AM

-- August 19, 2025 --

Presenting on Emerging Growth Conference 85 Day 1 on August 20; Register to live stream Globe Newswire 7:00 AM

-- August 18, 2025 --

Journey Medical Corporation to Present at the Emerging Growth Conference Globe Newswire 8:30 AM

-- August 12, 2025 --

Journey Medical Corporation Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights Globe Newswire 4:01 PM

-- August 7, 2025 --

Journey Medical Corporation to Ring Nasdaq Stock Market Closing Bell on August 11 Globe Newswire 8:30 AM

-- August 5, 2025 --

Journey Medical Corporation to Announce Second Quarter 2025 Financial Results on August 12, 2025 Globe Newswire 4:01 PM

-- July 14, 2025 --

Journey Medical Corporation Announces Expanded Payer Coverage for Emrosi Globe Newswire 8:30 AM
Market Data Delayed 15 Minutes